Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich CEO to Step Down in January; COO Nagarkatti to Take Helm

NEW YORK, Nov. 9 (GenomeWeb News) - Sigma-Aldrich Chairman and CEO and chairman David Harvey will step down as chief execxutive in January, the company said yesterday.


Jai Nagarkatti, the company's sitting president and chief operating officer, will take over as president and CEO beginning Jan. 1, the company said. Harvey will remain as chairman. Nagarkatti was also elected to the board.


According to the St. Louis-based life sciences company Nagarkatti has been with Sigma-Aldrich for nearly 30 years, holding positions in R&D, production, operations, and sales and marketing. He has been serving as COO and president since August 2004.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.